A Double-blind, Parallel-group, Comparative Study in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome
Latest Information Update: 13 Nov 2015
At a glance
- Drugs Ramosetron (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 06 Nov 2015 Primary endpoint has been met. (Monthly responder rate of stool form normalization at final point), according to an article published in the Gastroenterology
- 06 Nov 2015 Primary endpoint has been met. (Monthly responder rate of global assessment of relief of overall IBS symptoms at final point), according to an article published in the Gastroenterology
- 06 Nov 2015 Results published in the Gastroenterology